Advertisement
U.S. markets closed

MacroGenics, Inc. (MGNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
14.72-0.24 (-1.60%)
At close: 04:00PM EDT
14.72 0.00 (0.00%)
After hours: 07:52PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close14.96
Open14.74
Bid14.70 x 200
Ask14.79 x 600
Day's Range14.28 - 15.25
52 Week Range4.29 - 21.88
Volume771,111
Avg. Volume1,412,754
Market Cap918.999M
Beta (5Y Monthly)2.10
PE Ratio (TTM)N/A
EPS (TTM)-0.15
Earnings DateMay 07, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est24.78
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for MGNX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MacroGenics, Inc.
    Daily – Vickers Top Buyers & Sellers for 10/05/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    6 months agoArgus Research
View more
  • Insider Monkey

    MacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcript

    MacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcript March 7, 2024 MacroGenics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. We will begin the MacroGenics 2023 Fourth Quarter Corporate Progress and Financial Results Conference Call in just […]

  • Insider Monkey

    12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds

    In this article, we discuss 12 most undervalued biotech stocks to buy according to hedge funds. If you want to skip our discussion on the biotech industry, head over to 5 Most Undervalued Biotech Stocks To Buy According To Hedge Funds. Fitch Ratings maintains a Neutral outlook for the global pharmaceutical and biotech industry in […]

  • Thomson Reuters StreetEvents

    Q4 2023 MacroGenics Inc Earnings Call

    Q4 2023 MacroGenics Inc Earnings Call